From professional translators, enterprises, web pages and freely available translation repositories.
apex
apex
Last Update: 2011-10-23
Usage Frequency: 4
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
pētījums apex
adenuric adenuric
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
apex pētījums:
uuring apex:
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
nosaukums: ul apex co., ltd
nimi: ul apex co., ltd.
Last Update: 2014-11-06
Usage Frequency: 8
Quality:
apex -*nl x --(mod.)(16) -
apex -*nl x --(mod.)(16) -
Last Update: 2008-03-04
Usage Frequency: 3
Quality:
Reference:
(10 pacienti no 268 apex pētījumā).
509 patsienti kasutasid allopurinooli 300 mg üks kord päevas; 10 patsienti, kelle seerumi kreatiniinitase oli > 1, 5 ja < 2, 0 mg/ dl, kasutasid annust 100 mg üks kord päevas (uuringus apex 10 patsienti 268- st).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: Contains invisible HTML formatting
Warning: This alignment may be wrong.
Please delete it you feel so.
apex pētījumā gan adenuric 80 mg qd, gan adenuric 120 mg qd ļāva sasniegt statistiski nozīmīgi daudz labākus rezultātus par konvencionālajām allopurinola devām
uuring apex näitas nii adenuricit 80 mg üks kord päevas kui ka adenuricit 120 mg üks kord päevas kasutanud ravirühmades ravimi statistiliselt olulist paremust, võrreldes tavapäraseid allopurinooli annuseid 300 mg (n=258) / 100 mg (n=10) kasutanud ravirühmaga, seerumi kusihappetaseme (sua) vähendamisel alla 6 mg/ dl (357 µmol/ l) (vt tabelit 2 ja joonist 1).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
adrese: apex court, city link, nottingham, east midlands, united kingdom, ng2 4la -
aadress: apex court, city link, nottingham, east midlands, united kingdom, ng2 4la -
Last Update: 2008-03-04
Usage Frequency: 3
Quality:
Reference:
primārais kritērijs pacientiem ar sua ≥ 10 mg/ dl apmēram 40% pacientu (apex un fact kopā) sākotnējais sua bija ≥ 10 mg/ dl.
esmane tulemusnäitaja patsientide alarühmas, kellel sua ≥ 10 mg/ dl ligikaudu 40% - l patsientidest (apex ja fact kokku) oli ravi algul sua ≥ 10 mg/ dl.
Last Update: 2012-04-10
Usage Frequency: 4
Quality:
Reference: